The atypical Spitz tumor of uncertain biologic potential

BACKGROUND: Atypical Spitz tumors (AST) are rare spitzoid melanocytic proliferations with an uncertain malignant potential. ASTs have overlapping features of both Spitz nevi and spitzoid melanoma, and consequently generate controversy with diagnosis and management. Sentinel lymph node biopsy (SLNB)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2009-02, Vol.115 (3), p.631-641
Hauptverfasser: Ludgate, Mathew W., Fullen, Douglas R., Lee, Julia, Lowe, Lori, Bradford, Carol, Geiger, James, Schwartz, Jennifer, Johnson, Timothy M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 641
container_issue 3
container_start_page 631
container_title Cancer
container_volume 115
creator Ludgate, Mathew W.
Fullen, Douglas R.
Lee, Julia
Lowe, Lori
Bradford, Carol
Geiger, James
Schwartz, Jennifer
Johnson, Timothy M.
description BACKGROUND: Atypical Spitz tumors (AST) are rare spitzoid melanocytic proliferations with an uncertain malignant potential. ASTs have overlapping features of both Spitz nevi and spitzoid melanoma, and consequently generate controversy with diagnosis and management. Sentinel lymph node biopsy (SLNB) has been proposed as a possible means to gain additional insight into the true biologic potential of these tumors; however, previous reports on the use of SLNB in ASTs have been limited by small numbers of patients and short durations of follow‐up. METHODS: The authors extracted data from their institution's prospective melanoma database, collected between 1994 and 2007, for all patients with ASTs of uncertain biologic potential. They reviewed the clinical features of these patients, including the sentinel lymph node status, and the histological features of the tumors. RESULTS: A total of 67 patients with ASTs were identified, with a median age of 23.7 years. The mean depth was 2.4 mm. Of these, 57 had a SLNB performed, with 27 (47%) having a positive sentinel lymph node. SLNB‐positive cases had a significantly lower mean age than SLNB‐negative cases (17.9 vs 28.7 years; P = .013); however, no other significant differences were observed. All 27 patients with a positive SLNB were alive and disease free with median follow‐up of 43.8 months. One patient who did not receive a SLNB developed recurrent disease with regional and distant metastases. CONCLUSIONS: ASTs do not appear to behave like conventional melanoma. There is a high incidence of microscopic lymph node deposits in SLNBs, but despite this finding, patients have a favorable prognosis. Our findings raise several questions regarding the malignant potential of ASTs, and the role of SLNB in their management. Cancer 2009. © 2009 American Cancer Society. Atypical Spitz tumors are rare spitzoid melanocytic proliferations with an uncertain malignant potential. This study reveals a high incidence of microscopic lymph node deposits in sentinel lymph node biopsies performed for atypical Spitz tumors, but despite this finding, patients have a favorable prognosis.
doi_str_mv 10.1002/cncr.24047
format Article
fullrecord <record><control><sourceid>wiley</sourceid><recordid>TN_cdi_wiley_primary_10_1002_cncr_24047_CNCR24047</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CNCR24047</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1897-7f7b293b44b4808bf78874cff7e7872bb6daf7a3c72a9566a22c8163e5b7bfb23</originalsourceid><addsrcrecordid>eNotj8tKxDAYhYMoWEc3PkFeoOOfS_unSyneYFDQEdyFJCYa6bQlzSD16Z0ZXZ1zNt_hI-SSwZIB8CvXu7TkEiQekYJBgyUwyY9JAQCqrKR4OyVn0_S1m8grURC1_vTU5HmMznT0ZYz5h-btZkh0CHTbO5-yiT21ceiGj-joOGTf52i6c3ISTDf5i_9ckNfbm3V7X66e7h7a61XpmNrdY0DLG2GltFKBsgGVQulCQI8KubX1uwlohENumqquDedOsVr4yqINlosFYX_c79j5WY8pbkyaNQO9F9Z7YX0Q1u1j-3xo4hfPhku3</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The atypical Spitz tumor of uncertain biologic potential</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ludgate, Mathew W. ; Fullen, Douglas R. ; Lee, Julia ; Lowe, Lori ; Bradford, Carol ; Geiger, James ; Schwartz, Jennifer ; Johnson, Timothy M.</creator><creatorcontrib>Ludgate, Mathew W. ; Fullen, Douglas R. ; Lee, Julia ; Lowe, Lori ; Bradford, Carol ; Geiger, James ; Schwartz, Jennifer ; Johnson, Timothy M.</creatorcontrib><description>BACKGROUND: Atypical Spitz tumors (AST) are rare spitzoid melanocytic proliferations with an uncertain malignant potential. ASTs have overlapping features of both Spitz nevi and spitzoid melanoma, and consequently generate controversy with diagnosis and management. Sentinel lymph node biopsy (SLNB) has been proposed as a possible means to gain additional insight into the true biologic potential of these tumors; however, previous reports on the use of SLNB in ASTs have been limited by small numbers of patients and short durations of follow‐up. METHODS: The authors extracted data from their institution's prospective melanoma database, collected between 1994 and 2007, for all patients with ASTs of uncertain biologic potential. They reviewed the clinical features of these patients, including the sentinel lymph node status, and the histological features of the tumors. RESULTS: A total of 67 patients with ASTs were identified, with a median age of 23.7 years. The mean depth was 2.4 mm. Of these, 57 had a SLNB performed, with 27 (47%) having a positive sentinel lymph node. SLNB‐positive cases had a significantly lower mean age than SLNB‐negative cases (17.9 vs 28.7 years; P = .013); however, no other significant differences were observed. All 27 patients with a positive SLNB were alive and disease free with median follow‐up of 43.8 months. One patient who did not receive a SLNB developed recurrent disease with regional and distant metastases. CONCLUSIONS: ASTs do not appear to behave like conventional melanoma. There is a high incidence of microscopic lymph node deposits in SLNBs, but despite this finding, patients have a favorable prognosis. Our findings raise several questions regarding the malignant potential of ASTs, and the role of SLNB in their management. Cancer 2009. © 2009 American Cancer Society. Atypical Spitz tumors are rare spitzoid melanocytic proliferations with an uncertain malignant potential. This study reveals a high incidence of microscopic lymph node deposits in sentinel lymph node biopsies performed for atypical Spitz tumors, but despite this finding, patients have a favorable prognosis.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.24047</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>atypical Spitz tumor ; melanoma ; sentinel lymph node biopsy ; Spitz nevus</subject><ispartof>Cancer, 2009-02, Vol.115 (3), p.631-641</ispartof><rights>Copyright © 2009 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1897-7f7b293b44b4808bf78874cff7e7872bb6daf7a3c72a9566a22c8163e5b7bfb23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncr.24047$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncr.24047$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids></links><search><creatorcontrib>Ludgate, Mathew W.</creatorcontrib><creatorcontrib>Fullen, Douglas R.</creatorcontrib><creatorcontrib>Lee, Julia</creatorcontrib><creatorcontrib>Lowe, Lori</creatorcontrib><creatorcontrib>Bradford, Carol</creatorcontrib><creatorcontrib>Geiger, James</creatorcontrib><creatorcontrib>Schwartz, Jennifer</creatorcontrib><creatorcontrib>Johnson, Timothy M.</creatorcontrib><title>The atypical Spitz tumor of uncertain biologic potential</title><title>Cancer</title><description>BACKGROUND: Atypical Spitz tumors (AST) are rare spitzoid melanocytic proliferations with an uncertain malignant potential. ASTs have overlapping features of both Spitz nevi and spitzoid melanoma, and consequently generate controversy with diagnosis and management. Sentinel lymph node biopsy (SLNB) has been proposed as a possible means to gain additional insight into the true biologic potential of these tumors; however, previous reports on the use of SLNB in ASTs have been limited by small numbers of patients and short durations of follow‐up. METHODS: The authors extracted data from their institution's prospective melanoma database, collected between 1994 and 2007, for all patients with ASTs of uncertain biologic potential. They reviewed the clinical features of these patients, including the sentinel lymph node status, and the histological features of the tumors. RESULTS: A total of 67 patients with ASTs were identified, with a median age of 23.7 years. The mean depth was 2.4 mm. Of these, 57 had a SLNB performed, with 27 (47%) having a positive sentinel lymph node. SLNB‐positive cases had a significantly lower mean age than SLNB‐negative cases (17.9 vs 28.7 years; P = .013); however, no other significant differences were observed. All 27 patients with a positive SLNB were alive and disease free with median follow‐up of 43.8 months. One patient who did not receive a SLNB developed recurrent disease with regional and distant metastases. CONCLUSIONS: ASTs do not appear to behave like conventional melanoma. There is a high incidence of microscopic lymph node deposits in SLNBs, but despite this finding, patients have a favorable prognosis. Our findings raise several questions regarding the malignant potential of ASTs, and the role of SLNB in their management. Cancer 2009. © 2009 American Cancer Society. Atypical Spitz tumors are rare spitzoid melanocytic proliferations with an uncertain malignant potential. This study reveals a high incidence of microscopic lymph node deposits in sentinel lymph node biopsies performed for atypical Spitz tumors, but despite this finding, patients have a favorable prognosis.</description><subject>atypical Spitz tumor</subject><subject>melanoma</subject><subject>sentinel lymph node biopsy</subject><subject>Spitz nevus</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNotj8tKxDAYhYMoWEc3PkFeoOOfS_unSyneYFDQEdyFJCYa6bQlzSD16Z0ZXZ1zNt_hI-SSwZIB8CvXu7TkEiQekYJBgyUwyY9JAQCqrKR4OyVn0_S1m8grURC1_vTU5HmMznT0ZYz5h-btZkh0CHTbO5-yiT21ceiGj-joOGTf52i6c3ISTDf5i_9ckNfbm3V7X66e7h7a61XpmNrdY0DLG2GltFKBsgGVQulCQI8KubX1uwlohENumqquDedOsVr4yqINlosFYX_c79j5WY8pbkyaNQO9F9Z7YX0Q1u1j-3xo4hfPhku3</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Ludgate, Mathew W.</creator><creator>Fullen, Douglas R.</creator><creator>Lee, Julia</creator><creator>Lowe, Lori</creator><creator>Bradford, Carol</creator><creator>Geiger, James</creator><creator>Schwartz, Jennifer</creator><creator>Johnson, Timothy M.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope/></search><sort><creationdate>20090201</creationdate><title>The atypical Spitz tumor of uncertain biologic potential</title><author>Ludgate, Mathew W. ; Fullen, Douglas R. ; Lee, Julia ; Lowe, Lori ; Bradford, Carol ; Geiger, James ; Schwartz, Jennifer ; Johnson, Timothy M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1897-7f7b293b44b4808bf78874cff7e7872bb6daf7a3c72a9566a22c8163e5b7bfb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>atypical Spitz tumor</topic><topic>melanoma</topic><topic>sentinel lymph node biopsy</topic><topic>Spitz nevus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ludgate, Mathew W.</creatorcontrib><creatorcontrib>Fullen, Douglas R.</creatorcontrib><creatorcontrib>Lee, Julia</creatorcontrib><creatorcontrib>Lowe, Lori</creatorcontrib><creatorcontrib>Bradford, Carol</creatorcontrib><creatorcontrib>Geiger, James</creatorcontrib><creatorcontrib>Schwartz, Jennifer</creatorcontrib><creatorcontrib>Johnson, Timothy M.</creatorcontrib><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ludgate, Mathew W.</au><au>Fullen, Douglas R.</au><au>Lee, Julia</au><au>Lowe, Lori</au><au>Bradford, Carol</au><au>Geiger, James</au><au>Schwartz, Jennifer</au><au>Johnson, Timothy M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The atypical Spitz tumor of uncertain biologic potential</atitle><jtitle>Cancer</jtitle><date>2009-02-01</date><risdate>2009</risdate><volume>115</volume><issue>3</issue><spage>631</spage><epage>641</epage><pages>631-641</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>BACKGROUND: Atypical Spitz tumors (AST) are rare spitzoid melanocytic proliferations with an uncertain malignant potential. ASTs have overlapping features of both Spitz nevi and spitzoid melanoma, and consequently generate controversy with diagnosis and management. Sentinel lymph node biopsy (SLNB) has been proposed as a possible means to gain additional insight into the true biologic potential of these tumors; however, previous reports on the use of SLNB in ASTs have been limited by small numbers of patients and short durations of follow‐up. METHODS: The authors extracted data from their institution's prospective melanoma database, collected between 1994 and 2007, for all patients with ASTs of uncertain biologic potential. They reviewed the clinical features of these patients, including the sentinel lymph node status, and the histological features of the tumors. RESULTS: A total of 67 patients with ASTs were identified, with a median age of 23.7 years. The mean depth was 2.4 mm. Of these, 57 had a SLNB performed, with 27 (47%) having a positive sentinel lymph node. SLNB‐positive cases had a significantly lower mean age than SLNB‐negative cases (17.9 vs 28.7 years; P = .013); however, no other significant differences were observed. All 27 patients with a positive SLNB were alive and disease free with median follow‐up of 43.8 months. One patient who did not receive a SLNB developed recurrent disease with regional and distant metastases. CONCLUSIONS: ASTs do not appear to behave like conventional melanoma. There is a high incidence of microscopic lymph node deposits in SLNBs, but despite this finding, patients have a favorable prognosis. Our findings raise several questions regarding the malignant potential of ASTs, and the role of SLNB in their management. Cancer 2009. © 2009 American Cancer Society. Atypical Spitz tumors are rare spitzoid melanocytic proliferations with an uncertain malignant potential. This study reveals a high incidence of microscopic lymph node deposits in sentinel lymph node biopsies performed for atypical Spitz tumors, but despite this finding, patients have a favorable prognosis.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/cncr.24047</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 2009-02, Vol.115 (3), p.631-641
issn 0008-543X
1097-0142
language eng
recordid cdi_wiley_primary_10_1002_cncr_24047_CNCR24047
source Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects atypical Spitz tumor
melanoma
sentinel lymph node biopsy
Spitz nevus
title The atypical Spitz tumor of uncertain biologic potential
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T00%3A18%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20atypical%20Spitz%20tumor%20of%20uncertain%20biologic%20potential&rft.jtitle=Cancer&rft.au=Ludgate,%20Mathew%20W.&rft.date=2009-02-01&rft.volume=115&rft.issue=3&rft.spage=631&rft.epage=641&rft.pages=631-641&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.24047&rft_dat=%3Cwiley%3ECNCR24047%3C/wiley%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true